NuGen Medical Devices Inc Cash Flow Conversion Efficiency
NuGen Medical Devices Inc cash flow conversion efficiency. Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has a cash flow conversion efficiency ratio of 0.066x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.01 Million ≈ $-729.17K USD) by net assets (CA$-15.33 Million ≈ $-11.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NuGen Medical Devices Inc (2020–2025)
Cash flow conversion efficiency of NuGen Medical Devices Inc from 2020 to 2025. This chart illustrates how NuGen Medical Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of NuGen Medical Devices Inc for real-time trading data and today's change.
NuGen Medical Devices Inc Cash Flow Conversion Ratio Explained
NuGen Medical Devices Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NuGen Medical Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NuGen Medical Devices Inc ranked by their cash flow conversion efficiency. Also see NGMD company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Imagine Lithium Inc
V:ILI
|
-0.005x |
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
0.032x |
|
Nrgene Technologies Ltd
TA:NRGN
|
0.392x |
|
Williamson Magor & Company Limited
NSE:WILLAMAGOR
|
-0.196x |
|
Global Power Solutions Corp.
V:PWER
|
0.240x |
|
SIGNATURE RESOURCES NEW
F:3S30
|
1.468x |
|
Nuwellis Inc
NASDAQ:NUWE
|
1.553x |
|
Lanesborough Real Estate Investment Trust
V:LRT-UN
|
0.011x |
Annual Cash Flow Conversion Efficiency for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual cash flow conversion efficiency of NuGen Medical Devices Inc from 2020 to 2025. Review NGMD financial flexibility score to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-13.74 Million ≈ $-9.94 Million |
CA$-3.57 Million ≈ $-2.58 Million |
0.260x | -68.76% |
| 2024-12-31 | CA$-5.67 Million ≈ $-4.10 Million |
CA$-4.71 Million ≈ $-3.41 Million |
0.831x | -74.50% |
| 2023-12-31 | CA$-2.06 Million ≈ $-1.49 Million |
CA$-6.71 Million ≈ $-4.86 Million |
3.259x | +51.03% |
| 2022-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-4.88 Million ≈ $-3.53 Million |
2.158x | +187.35% |
| 2021-12-31 | CA$1.66 Million ≈ $1.20 Million |
CA$-4.10 Million ≈ $-2.96 Million |
-2.470x | -222.69% |
| 2020-12-31 | CA$-692.25K ≈ $-500.76K |
CA$-1.39 Million ≈ $-1.01 Million |
2.013x | -- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more